In the case reports of Palmer et al. [22], Faisal et al. [20] and Naymagon et al. [18], MetHb increased in the COVID-19 patients during the course of the disease. Data of multiple MetHb measurements during the disease course were published by Palmer et al. [22], showing a rise of MetHb to a peak after a few days and a decline after treatment (Figure 3d).